Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1: pooled analysis of two phase 3 trials.

CONCLUSION: Addition of faldaprevir to PegIFN/RBV increased SVR12 in patients with HCV genotype-1, and was well tolerated. Faldaprevir 120 mg is effective in the treatment of HCV genotype-1. ClinicalTrials.gov: NCT01343888 and NCT01297270. PMID: 27049487 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/27049487?dopt=Abstract

Source: Annals of Hepatology - April 8, 2016 Category: Gastroenterology Tags: Ann Hepatol Source Type: research